Road to Alzheimer's Disease: The Pathomechanism Underlying

被引:13
作者
Anand, R. [1 ]
Kaushal, Alka [1 ]
Wani, Willayat Yousuf [1 ]
Gill, Kiran Dip [1 ]
机构
[1] Postgrad Inst Med Educ & Res, Dept Biochem, Chandigarh 160012, India
关键词
Alzheimer's disease; Amyloid; Dementia; Neurofibrillary tangles; Oxidative stress; Senile plaques; Tau protein; AMYLOID-BETA-PEPTIDE; BLOOD-BRAIN-BARRIER; INDUCED NEURONAL APOPTOSIS; MILD COGNITIVE IMPAIRMENT; MESSENGER-RNA EXPRESSION; OXIDATIVE STRESS; PRECURSOR PROTEIN; APOLIPOPROTEIN-E; GENE-EXPRESSION; NEUROFIBRILLARY TANGLES;
D O I
10.1159/000332218
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Alzheimer's disease (AD), the most common cause of dementia, results from the interplay of various deregulated mechanisms triggering a complex pathophysiology. The neurons suffer from and slowly succumb to multiple irreversible damages, resulting in cell death and thus memory deficits that characterize AD. In spite of our vast knowledge, it is still unclear as to when the disease process starts and how long the perturbations continue before the disease manifests. Recent studies provide sufficient evidence to prove amyloid beta (A beta) as the primary cause initiating secondary events, but A beta is also known to be produced under normal conditions and to possess physiological roles, hence, the questions that remain are: What are the factors that lead to abnormal A beta production? When does A beta turn into a pathological molecule? What is the chain of events that follows A beta? The answers are still under debate, and further insight may help us in creating better diagnostic and therapeutic options in AD. The present article attempts to review the current literature regarding AD pathophysiology and proposes a pathophysiologic cascade in AD. Copyright (C) 2011 S. Karger AG, Basel
引用
收藏
页码:55 / 71
页数:17
相关论文
共 50 条
[31]   A Look at the Etiology of Alzheimer's Disease based on the Brain Ischemia Model [J].
Pluta, Ryszard .
CURRENT ALZHEIMER RESEARCH, 2024, 21 (03) :166-182
[32]   The role of trimethylamine-N-Oxide in the development of Alzheimer's disease [J].
Buawangpong, Nida ;
Pinyopornpanish, Kanokporn ;
Siri-Angkul, Natthapat ;
Chattipakorn, Nipon ;
Chattipakorn, Siriporn C. .
JOURNAL OF CELLULAR PHYSIOLOGY, 2022, 237 (03) :1661-1685
[33]   Apolipoprotein E and oxidative stress in brain with relevance to Alzheimer's disease [J].
Butterfield, D. Allan ;
Mattson, Mark P. .
NEUROBIOLOGY OF DISEASE, 2020, 138
[34]   The pathological process underlying Alzheimer's disease in individuals under thirty [J].
Braak, Heiko ;
Del Tredici, Kelly .
ACTA NEUROPATHOLOGICA, 2011, 121 (02) :171-181
[35]   An Analysis of the Neurological and Molecular Alterations Underlying the Pathogenesis of Alzheimer's Disease [J].
Vidal, Chantal ;
Zhang, Li .
CELLS, 2021, 10 (03) :1-28
[36]   The pathological process underlying Alzheimer’s disease in individuals under thirty [J].
Heiko Braak ;
Kelly Del Tredici .
Acta Neuropathologica, 2011, 121 :171-181
[37]   Inverse relationship between Alzheimer's disease and cancer, and other factors contributing to Alzheimer's disease: a systematic review [J].
Shafi, Ovais .
BMC NEUROLOGY, 2016, 16
[38]   Bridging the Gap between Alzheimer's Disease and Alzheimer's-like Diseases in Animals [J].
Golaszewska, Anita ;
Bik, Wojciech ;
Motyl, Tomasz ;
Orzechowski, Arkadiusz .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (07)
[39]   Alzheimer's Disease Treatment: The Search for a Breakthrough [J].
Reiss, Allison B. ;
Muhieddine, Dalia ;
Jacob, Berlin ;
Mesbah, Michael ;
Pinkhasov, Aaron ;
Gomolin, Irving H. ;
Stecker, Mark M. ;
Wisniewski, Thomas ;
De Leon, Joshua .
MEDICINA-LITHUANIA, 2023, 59 (06)
[40]   Targeted Nanoparticles for the Treatment of Alzheimer's Disease [J].
Martin-Rapun, Rafael ;
De Matteis, Laura ;
Ambrosone, Alfredo ;
Garcia-Embid, Sonia ;
Gutierrez, Lucia ;
de la Fuente, Jesus M. .
CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (13) :1927-1952